Table 2 Recurrent and persistent cases of bacteremia due to Helicobacter spp.
No. | Age sex | Underlying diseases | Clinical manifestations | Immunosuppressants | Initial ABXs (days) | Duration from discontinuation of ABXs to recurrence (days) | ABX regimens after re-starting or changing the ABXs | Total duration of ABXs (days) |
|---|---|---|---|---|---|---|---|---|
Recurrence | ||||||||
1 | 40s Male | Small bowel obstruction Chronic diarrhea | Skin lesion | None | SAM (13) >AMX (14) | 8 | CRO AMX + DOX | 115 |
2 | 70s M | Lung adenocarcinoma Metastatic lesion | FN | Gefitinib Carboplatin Pemetrexed | SAM (4) >FEP (16) | 11 | FEP AMX + DOX | 41 |
3 | 50s Male | Lung ewing sarcoma | FN Skin lesion | Vincristine Doxorubicin Cyclophosphamide Ifosfamide Etoposide | FEP (10) | 13 | FEP AMX + DOX | 51 |
Persistent bacteremia | ||||||||
1 | 60s Male | Tibial plateau fracture (after operation) | Skin lesion Joint infection | None | CFZ (11) | – | MEM DOX | 85 |
2 | 80s Female | Osteoarthritis (after TKA) Hodgkin disease (complete remission) | Skin lesion Joint infection | None | CLR (19) | – | MEM AMX + DOX | 89 |